Provided by Tiger Trade Technology Pte. Ltd.

Twist Bioscience Corp

151.42
+10.627.54%
Post-market: 151.900.4800+0.32%19:58 EDT
Volume:2.08M
Turnover:314.78M
Market Cap:9.50B
PE:-67.92
High:154.96
Open:145.73
Low:141.41
Close:140.80
52wk High:154.96
52wk Low:23.30
Shares:62.71M
Float Shares:61.76M
Volume Ratio:0.96
T/O Rate:3.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2293
EPS(LYR):-1.2987
ROE:-29.59%
ROA:-13.09%
PB:21.30
PE(LYR):-116.60

Loading ...

GUIDANCE: (TWST) Twist Bioscience Expects Fiscal 2026 Revenue Range $456M - $457M, vs. FactSet Est of $446.4M

MT Newswires Live
·
Aug 03

Twist Bioscience Q3 EPS $(0.56) Misses $(0.50) Estimate, Sales $118.376M Beat $114.490M Estimate

Benzinga Earnings
·
Aug 03

Earnings Flash (TWST) Twist Bioscience Posts Fiscal Q3 Loss $0.56 a Share, vs. FactSet Est of $0.51 Loss

MT Newswires Live
·
Aug 03

Twist Bioscience FY26 Q3 Adjusted Ebitda Loss Narrows to $(11.3) Million; Revenue Rises 23% YoY to $118.4 Million

Reuters
·
Aug 03

Twist Bioscience Q3 EPS USD -0.56

THOMSON REUTERS
·
Aug 03

Twist Bioscience Outlook Q4 to Achieve Adjusted Ebitda Breakeven

THOMSON REUTERS
·
Aug 03

Twist Bioscience Outlook FY Gross Margin to be Above 52%

THOMSON REUTERS
·
Aug 03

Twist Bioscience Posts Fiscal Q3 2026 Earnings Report and Investor Presentation Online

Reuters
·
Aug 03

Twist Bioscience Corp: for the Fourth Quarter, Twist Expects Total Revenue of Approximately $123 Million to $124 Million

THOMSON REUTERS
·
Aug 03

Twist Bioscience Corp: Q3 Net Loss $0.56 Per Diluted Share

THOMSON REUTERS
·
Aug 03

Twist Bioscience Corp: Raises FY26 Revenue Guidance to $456-457M from $442-447M

THOMSON REUTERS
·
Aug 03

Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results

THOMSON REUTERS
·
Aug 03

U.S. Earnings Preview: Before Market Open Aug. 3

Dow Jones
·
Aug 03

Movement Alert|Twist Bioscience Corp Falls 5.12% in Regular Trading, Trading at $85.72

Market Focus
·
Jul 28

Earning Preview: Twist Bioscience Corp this quarter’s revenue is expected to increase by 19.73%, and institutional views are mostly bullish

Earnings Agent
·
Jul 27

Movement Alert|Twist Bioscience Rises 5.54% in Regular Trading, Trading at $92.3

Market Focus
·
Jul 21

Movement Alert|Twist Bioscience Falls 5.04% in Regular Trading, Trading at $89.02

Market Focus
·
Jul 21

Movement Alert|Twist Bioscience Falls 5.24% in Regular Trading, Trading at $91.11

Market Focus
·
Jul 17

Twist Bioscience price target raised to $110 from $80 at Leerink

TIPRANKS
·
Jul 16

Press Release: Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026

Dow Jones
·
Jul 15